Video

EXTEND-IA Trial Shows Continued Endovascular Therapy Development

Author(s):

As more endovascular therapy options are developed doctors will have the chance to learn a variety of methods and decide which will work best for their individual patients.

As more endovascular therapy options are developed for treating stroke doctors will have the chance to learn a variety of methods and decide which will work best for their individual patients.

Bruce Campbell, MBBS, PhD, FRACP, from the Royal Melbourne Hospital in Australia discussed the results of the EXTEND-IA Trial during the International Stroke Conference in Nashville.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Experts' Perspectives: Top Stories in Cardiology for 2024
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
© 2025 MJH Life Sciences

All rights reserved.